Business Wire

NY-JEFFERIES-FINANCIAL

Share
Jefferies' Clients, Employees and Shareholders Contribute $9,250,000 to Over 85 Charities for Coronavirus Relief in Memory of Peg Broadbent

Jefferies announced today a total donation to over 85 different charities of $9.25 million as a result of a firmwide global effort to raise money to honor the memory of their late CFO Peg Broadbent, who was a victim of this terrible disease.

Through the firm’s Global Coronavirus Relief Charity Day held May 27th, Jefferies’ clients helped to generate $7.65 million in donated net trading commissions. In addition, Jefferies as a firm will donate $1 million directly, and voluntary donations from Jefferies’ 3,822 employees totaled $600,000.

“We could not be prouder of our entire Jefferies family for raising $9.25 million and are greatly appreciative of the incredible partnership our clients have shown us in supporting our fight against Covid-19. The full $9.25 million will be wired today and go to direct relief efforts at over 85 worthy global charities who are each in the front lines helping those most impacted by the Coronavirus global pandemic. We went broadly to a large number of charities globally as this is truly a tragedy that affects all of us and, in particular, those who are most disadvantaged and in the greatest need.

The charities selected are both big and small and represent everything from food banks, child care services, assistance with PPE and other medical supplies, support for front line medical workers, assistance for afflicted military personnel, local teen centers, support for police and fire, workforce training and re-training and many other worthy areas that are most in need. We thank our employees and clients for aiding in the selection of many of these remarkable charities.

Finally, all of us at Jefferies would like to thank all the dedicated professionals working tirelessly on the front line to help those in need. They are the true heroes whom we are honored to help in Peg’s name.”

Contributions in the following amounts will be immediately distributed to these respected organizations:

NYC Mayor’s Fund | Peg’s Cure

 

$ 150,000

All Hands and Hearts

 

$ 150,000

American Heart Association

$ 150,000

Bowery Mission

$ 150,000

Hackensack Meridian Health Foundation

$ 150,000

Houston Police Foundation

 

$ 150,000

International Rescue Committee

 

$ 150,000

Robin Hood Foundation

 

$ 150,000

Strive

 

$ 150,000

The Bass Foundation

 

$ 150,000

World Central Kitchen

 

$ 150,000

We Can #TogetherFromHome

 

$ 100,000

Achievement First

 

$ 100,000

Aktion Deutschland Hilft

 

$ 100,000

Alzheimer’s Association

 

$ 100,000

Ambitious About Autism

 

$ 100,000

Barnardo’s

$ 100,000

BMS Family Health and Wellness Center

 

$ 100,000

Bob Woodruff Foundation

 

$ 100,000

Boys & Girls Clubs of the Austin Area

 

$ 100,000

Brewers Community Foundation

 

$ 100,000

Buttle UK

 

$ 100,000

Central Texas Food Bank

 

$ 100,000

Chelsea and Westminster Hospital NHS Foundation Trust

 

$ 100,000

Chrysalis

$ 100,000

City Harvest

$ 100,000

Citymeals on Wheels

 

$ 100,000

Columbia Children's Hospital

 

$ 100,000

Community Food Bank of New Jersey

 

$ 100,000

Covenant House

 

$ 100,000

Doctors Without Borders

 

$ 100,000

East High – EOP (Education Partnership Organization)

 

$ 100,000

Elmhurst Hospital Charity

 

$ 100,000

Family Promise of Bergen County

 

$ 100,000

FarmLink

 

$ 100,000

Feeding America

 

$ 100,000

Food Bank For New York City

 

$ 100,000

Foodlink

 

$ 100,000

Habitat for Humanity Japan

 

$ 100,000

Hance Family Foundation

 

$ 100,000

Humanity & Inclusion

 

$ 100,000

Hunger Free America

 

$ 100,000

Imperial Health Charity

 

$ 100,000

Kids in Crisis

 

$ 100,000

Kohka Foundation

 

$ 100,000

Lahey Clinic Foundation

 

$ 100,000

Mail Force Charity

 

$ 100,000

Martha’s Table

 

$ 100,000

Médecins Sans Frontières

 

$ 100,000

Memorial Hermann Foundation

 

$ 100,000

My Sister's Place

 

$ 100,000

National Emergencies Trust

 

$ 100,000

Navajo Nation Covid-19 Relief Fund

 

$ 100,000

Nazareth Housing

 

$ 100,000

Neighbourly Community Fund

 

$ 100,000

NHS Charities Together

 

$ 100,000

Northwell Health's COVID-19 Emergency Fund

 

$ 100,000

NYU Langone

 

$ 100,000

Off Their Plate

 

$ 100,000

Oxfam India

 

$ 100,000

Philippine Disaster Resilience Foundation

 

$ 100,000

Red Hook Initiative

 

$ 100,000

Rosetree Trust

 

$ 100,000

Royal College of Nursing Foundation

 

$ 100,000

RVNAhealth

 

$ 100,000

Second Harvest

 

$ 100,000

Sempre Con Voi (Always with You)

 

$ 100,000

St Michael’s House

 

$ 100,000

TBD 1

 

$ 100,000

TBD 2

 

$ 100,000

TBD 3

 

$ 100,000

TCF Bank

 

$ 100,000

The Care Workers Charity

 

$ 100,000

The River Fund New York

 

$ 100,000

The United Way of Central Indiana COVID-19 Relief Fund

 

$ 100,000

The World Health Organization (WHO)

 

$ 100,000

Trinity's Services & Food for the Homeless

 

$ 100,000

The Trussell Trust

 

$ 100,000

UNICEF

 

$ 100,000

UR Medicine Home Care’s Meals on Wheels

 

$ 100,000

URMC COVID-19 Emergency Fund

 

$ 100,000

Valpo Surf Project, Inc.

 

$ 100,000

Volunteers of Legal Service

 

$ 100,000

Our Dream Their Smile

 

$ 100,000

West Side Campaign Against Hunger

 

$ 100,000

Women United in Philanthropy

 

$ 100,000

Women's Center of Greater Danbury

 

$ 100,000

 

 


$ 9,250,000

Jefferies Group LLC is the largest independent, global, full-service investment banking firm headquartered in the U.S. Focused on serving clients for nearly 60 years, Jefferies is a leader in providing insight, expertise and execution to investors, companies and governments. Our firm provides a full range of investment banking, advisory, sales and trading, research and wealth management services across all products in the Americas, Europe and Asia. Jefferies Group LLC is a wholly owned subsidiary of Jefferies Financial Group Inc. (NYSE: JEF), a diversified financial services company.

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Andersen Consulting tilføjer samarbejdsfirmaet Codezilla7.12.2025 21:19:00 CET | Pressemeddelelse

Andersen Consulting styrker sine kompetencer inden for digital transformation gennem en samarbejdsaftale med Codezilla, et firma med hovedsæde i Rumænien, der udvikler specialtilpasset software. Codezilla specialiserer sig i at udvikle skræddersyede softwareprodukter, der løser forretningsmæssige udfordringer gennem en tværfaglig tilgang, som kombinerer softwareudvikling med dybdegående marketingekspertise. Med over 30 år på markedet fungerer firmaet som implementerings- og digital konsulentressource for reklamebureauer, samtidig med at de arbejder med en bred kundebase, herunder virksomheder inden for sundhedssektoren og medicinsk udstyr. Codezillas interne teams strækker sig over teknik, design og strategi og leverer omnichannel-løsninger til både regionale og globale kunder. "Vi tror på, at fantastisk software er resultatet af solid ingeniørkunst og disciplineret eksekvering," udtaler Sebastian Doroftei, administrerende direktør for Codezilla. "Vores samarbejde med Andersen Consulti

Hemato-Oncology Trials: AOP Health Presents New Results at Top Congress ASH7.12.2025 17:00:00 CET | Press release

AOP Health continues to advance its clinical research program in myeloproliferative neoplasms, a special group of rare blood cancers. The company, specialized in rare diseases, presented the results of two scientific investigations at the 67th American Society of Hematology Association (ASH) Annual Meeting 2025 held in Orlando, FL, USA. The results provide new insights in treatment strategies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251207587915/en/ Dr. Martin Steinhart, CEO AOP Health; Photo credit: AOP Health/Studio Koekart ROP-ET and BESREMI PASS One of the clinical studies, ROP-ET, examined the use of ropeginterferon alfa-2b in people with essential thrombocythemia (ET), a disease in which the body produces too many platelets. The trial, a prospective, multicenter, single-arm phase III study, investigated the safety and efficacy of ropeginterferon alfa-2b in ET patients unable to receive available cytoreductive th

CoMotion GLOBAL 2025 Launches in Riyadh: Global Mobility Leaders Unite in Saudi Capital to Chart Urban Future7.12.2025 13:00:00 CET | Press release

Summit debuts Mayors in Motion initiative and CoMotion Urban Visionary Distinction as Riyadh showcases its rise as global mobility testbed Riyadh is rapidly becoming one of the world's most ambitious urban mobility laboratories, where next-generation technologies move from blueprint to real-world deployment on city streets at unprecedented scale. CoMotion GLOBAL 2025, the world's most influential gathering of urban mobility leaders, opens today in Riyadh for a three-day summit bringing together innovators from Africa, Asia, Europe, the Americas, and the Middle East. Running December 7-9, the event will explore how electrification, autonomy, AI-enabled transport, and giga-project urbanism are reshaping cities worldwide. The summit will spotlight everything from high-performance EVs and breakthrough autonomous fleets to emerging-market transport solutions and new mobility models, demonstrating how the Kingdom is opening new pathways for global mobility leadership. Strategic Partnerships

Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release

Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On

Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 15:30:00 CET | Press release

52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye